Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-26-036093
Filing Date
2026-03-27
Accepted
2026-03-27 16:05:18
Documents
1
Period of Report
2026-03-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm269997-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm269997-1_4seq1.xml 4 4707
  Complete submission text file 0001104659-26-036093.txt   6336
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 200 SAN DIEGO CA 92121
Business Address
Banjak Marc (Reporting) CIK: 0002033869 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35023 | Film No.: 26807249